| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pleural Neoplasms | 43 | 2024 | 609 | 4.750 |
Why?
|
| Mesothelioma | 54 | 2024 | 807 | 4.630 |
Why?
|
| Pneumonectomy | 22 | 2021 | 1119 | 1.330 |
Why?
|
| Hyperparathyroidism, Secondary | 5 | 2019 | 125 | 1.290 |
Why?
|
| Fibroblast Growth Factors | 10 | 2020 | 865 | 1.060 |
Why?
|
| Fundoplication | 5 | 2015 | 144 | 1.000 |
Why?
|
| Lung Neoplasms | 48 | 2024 | 13382 | 0.870 |
Why?
|
| Cisplatin | 9 | 2020 | 1650 | 0.840 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 8 | 2016 | 1650 | 0.760 |
Why?
|
| Receptors, Calcium-Sensing | 4 | 2019 | 318 | 0.740 |
Why?
|
| Hyperthermia, Induced | 5 | 2020 | 417 | 0.690 |
Why?
|
| Esophageal Achalasia | 4 | 2006 | 94 | 0.690 |
Why?
|
| Gastroesophageal Reflux | 7 | 2018 | 821 | 0.650 |
Why?
|
| Neoplasm Staging | 23 | 2021 | 11116 | 0.640 |
Why?
|
| Intestinal Fistula | 1 | 2019 | 142 | 0.600 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 86 | 0.590 |
Why?
|
| Laparoscopy | 9 | 2018 | 2030 | 0.570 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 455 | 0.570 |
Why?
|
| Esophagus | 6 | 2004 | 1031 | 0.540 |
Why?
|
| Gastric Bypass | 3 | 2010 | 818 | 0.500 |
Why?
|
| Osteogenesis | 9 | 2016 | 1270 | 0.490 |
Why?
|
| Esophagoscopy | 2 | 2015 | 397 | 0.470 |
Why?
|
| Tissue Fixation | 3 | 2020 | 241 | 0.460 |
Why?
|
| Obesity, Morbid | 4 | 2010 | 1276 | 0.450 |
Why?
|
| Bone Diseases, Metabolic | 4 | 2012 | 409 | 0.420 |
Why?
|
| Wnt Proteins | 4 | 2014 | 718 | 0.410 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2020 | 2801 | 0.410 |
Why?
|
| Nephrectomy | 1 | 2017 | 937 | 0.400 |
Why?
|
| Peptides | 3 | 2017 | 4354 | 0.400 |
Why?
|
| Intraoperative Care | 2 | 2013 | 767 | 0.380 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 18 | 2019 | 5319 | 0.360 |
Why?
|
| Gastric Emptying | 3 | 2011 | 243 | 0.360 |
Why?
|
| Spheroids, Cellular | 5 | 2019 | 329 | 0.350 |
Why?
|
| Autophagy | 4 | 2019 | 1326 | 0.340 |
Why?
|
| Bone and Bones | 4 | 2011 | 2565 | 0.340 |
Why?
|
| Catheter Ablation | 3 | 2015 | 2634 | 0.320 |
Why?
|
| Parathyroid Hormone | 5 | 2019 | 1803 | 0.310 |
Why?
|
| Osteoblasts | 8 | 2020 | 1141 | 0.300 |
Why?
|
| Gastrectomy | 3 | 2012 | 671 | 0.290 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2020 | 1608 | 0.280 |
Why?
|
| Stomach | 1 | 2011 | 695 | 0.280 |
Why?
|
| Frozen Sections | 1 | 2007 | 153 | 0.270 |
Why?
|
| Antineoplastic Agents | 12 | 2020 | 13635 | 0.270 |
Why?
|
| Male | 102 | 2024 | 360358 | 0.270 |
Why?
|
| Technology Transfer | 1 | 2006 | 42 | 0.270 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 257 | 0.270 |
Why?
|
| Renal Insufficiency | 3 | 2017 | 808 | 0.260 |
Why?
|
| Prognosis | 31 | 2021 | 29600 | 0.260 |
Why?
|
| Pleura | 2 | 2008 | 244 | 0.250 |
Why?
|
| Adenocarcinoma | 13 | 2020 | 6340 | 0.250 |
Why?
|
| Middle Aged | 75 | 2024 | 220584 | 0.250 |
Why?
|
| Gene Expression Profiling | 15 | 2019 | 9417 | 0.250 |
Why?
|
| Humans | 154 | 2024 | 760617 | 0.240 |
Why?
|
| Laparotomy | 1 | 2007 | 456 | 0.230 |
Why?
|
| Antibodies, Bispecific | 2 | 2018 | 196 | 0.230 |
Why?
|
| Microcomputers | 1 | 2004 | 141 | 0.230 |
Why?
|
| Aged | 62 | 2024 | 169042 | 0.220 |
Why?
|
| Calcimimetic Agents | 3 | 2019 | 12 | 0.220 |
Why?
|
| Bioterrorism | 1 | 2004 | 144 | 0.220 |
Why?
|
| Postoperative Complications | 10 | 2019 | 15612 | 0.220 |
Why?
|
| Osteocalcin | 3 | 2017 | 274 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 6 | 2010 | 4408 | 0.220 |
Why?
|
| Formaldehyde | 3 | 2020 | 357 | 0.210 |
Why?
|
| Phenethylamines | 3 | 2019 | 95 | 0.210 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2014 | 841 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2017 | 8166 | 0.210 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 2249 | 0.210 |
Why?
|
| Dyslipidemias | 1 | 2010 | 868 | 0.210 |
Why?
|
| Combined Modality Therapy | 11 | 2020 | 8516 | 0.210 |
Why?
|
| Gene Expression | 12 | 2016 | 7568 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2020 | 8542 | 0.200 |
Why?
|
| Female | 80 | 2024 | 392148 | 0.200 |
Why?
|
| Paraffin Embedding | 3 | 2020 | 302 | 0.200 |
Why?
|
| Aged, 80 and over | 28 | 2024 | 58894 | 0.200 |
Why?
|
| CA-125 Antigen | 1 | 2024 | 276 | 0.190 |
Why?
|
| Rats | 14 | 2019 | 23717 | 0.190 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 2413 | 0.190 |
Why?
|
| Thoracic Neoplasms | 3 | 2019 | 267 | 0.190 |
Why?
|
| Cell Line, Tumor | 20 | 2022 | 16967 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2024 | 9277 | 0.190 |
Why?
|
| Hernia, Hiatal | 1 | 2002 | 90 | 0.190 |
Why?
|
| Universities | 1 | 2006 | 992 | 0.180 |
Why?
|
| Animals | 49 | 2021 | 168201 | 0.180 |
Why?
|
| Mediastinal Emphysema | 1 | 2000 | 29 | 0.180 |
Why?
|
| Adult | 57 | 2024 | 220969 | 0.180 |
Why?
|
| Manometry | 5 | 2005 | 454 | 0.180 |
Why?
|
| Biphenyl Compounds | 2 | 2019 | 1007 | 0.180 |
Why?
|
| Calcium | 4 | 2017 | 5717 | 0.180 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2002 | 783 | 0.180 |
Why?
|
| Membrane Proteins | 6 | 2022 | 7847 | 0.180 |
Why?
|
| Survival Rate | 13 | 2018 | 12719 | 0.180 |
Why?
|
| Deoxycytidine | 2 | 2018 | 878 | 0.170 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2014 | 285 | 0.170 |
Why?
|
| Psychotherapy, Group | 1 | 2023 | 413 | 0.170 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 170 | 0.170 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2020 | 163 | 0.160 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2019 | 872 | 0.160 |
Why?
|
| Drug Design | 1 | 2004 | 1045 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2019 | 2895 | 0.160 |
Why?
|
| Cell Culture Techniques | 4 | 2019 | 1662 | 0.160 |
Why?
|
| Bone Remodeling | 2 | 2020 | 581 | 0.160 |
Why?
|
| Mice | 31 | 2021 | 81368 | 0.160 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2018 | 26 | 0.160 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2018 | 50 | 0.150 |
Why?
|
| Cell Line | 12 | 2018 | 15576 | 0.150 |
Why?
|
| RNA, Messenger | 8 | 2020 | 12758 | 0.150 |
Why?
|
| HMGB1 Protein | 1 | 2019 | 136 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 1169 | 0.150 |
Why?
|
| Omeprazole | 1 | 2018 | 105 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2012 | 3672 | 0.150 |
Why?
|
| Immunohistochemistry | 10 | 2020 | 11069 | 0.150 |
Why?
|
| Tumor Burden | 3 | 2018 | 1892 | 0.150 |
Why?
|
| Kidney Function Tests | 2 | 2017 | 678 | 0.140 |
Why?
|
| Parathyroid Glands | 2 | 2017 | 518 | 0.140 |
Why?
|
| Blood Urea Nitrogen | 1 | 2017 | 185 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2020 | 4020 | 0.140 |
Why?
|
| Immunophenotyping | 3 | 2017 | 1865 | 0.140 |
Why?
|
| Cell Nucleus | 4 | 2020 | 2894 | 0.140 |
Why?
|
| Neoadjuvant Therapy | 5 | 2015 | 2827 | 0.140 |
Why?
|
| Heat-Shock Proteins | 1 | 2021 | 795 | 0.140 |
Why?
|
| Colon | 2 | 2020 | 1791 | 0.140 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2016 | 198 | 0.140 |
Why?
|
| Signal Transduction | 10 | 2020 | 23416 | 0.140 |
Why?
|
| Bone Diseases | 1 | 2020 | 418 | 0.140 |
Why?
|
| Argininosuccinate Synthase | 1 | 2016 | 16 | 0.130 |
Why?
|
| Bone Resorption | 4 | 2012 | 723 | 0.130 |
Why?
|
| Erythropoiesis | 1 | 2020 | 684 | 0.130 |
Why?
|
| Kidney | 5 | 2018 | 7045 | 0.130 |
Why?
|
| Muscle, Smooth | 4 | 2006 | 927 | 0.130 |
Why?
|
| Phosphorus | 1 | 2017 | 335 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2017 | 350 | 0.130 |
Why?
|
| Uremia | 1 | 2017 | 202 | 0.130 |
Why?
|
| DNA Mutational Analysis | 3 | 2020 | 4110 | 0.130 |
Why?
|
| Retrospective Studies | 22 | 2021 | 80566 | 0.130 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2005 | 129 | 0.130 |
Why?
|
| Bone Density | 6 | 2016 | 3548 | 0.130 |
Why?
|
| Glucuronidase | 1 | 2017 | 202 | 0.130 |
Why?
|
| Phosphates | 3 | 2017 | 769 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 737 | 0.130 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 166 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2018 | 373 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2017 | 561 | 0.120 |
Why?
|
| AMP Deaminase | 1 | 2014 | 5 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2018 | 930 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2008 | 1056 | 0.120 |
Why?
|
| Calcitriol | 2 | 2017 | 296 | 0.120 |
Why?
|
| Neurofibromin 2 | 1 | 2016 | 270 | 0.120 |
Why?
|
| CHO Cells | 3 | 2012 | 1387 | 0.120 |
Why?
|
| beta Catenin | 3 | 2017 | 1039 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 5 | 2015 | 1784 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 7 | 2015 | 3514 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 1132 | 0.120 |
Why?
|
| Glucose | 3 | 2016 | 4345 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2013 | 2495 | 0.120 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2016 | 86 | 0.120 |
Why?
|
| Computational Biology | 3 | 2014 | 3509 | 0.120 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2013 | 350 | 0.120 |
Why?
|
| Esophagogastric Junction | 3 | 2004 | 347 | 0.120 |
Why?
|
| Kupffer Cells | 1 | 2015 | 143 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2014 | 42 | 0.120 |
Why?
|
| Mesentery | 1 | 1995 | 202 | 0.120 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 393 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2017 | 1150 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 106 | 0.110 |
Why?
|
| Vasodilation | 1 | 2018 | 962 | 0.110 |
Why?
|
| Cricetinae | 3 | 2012 | 2424 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2013 | 5789 | 0.110 |
Why?
|
| Microvessels | 1 | 2018 | 577 | 0.110 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 359 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2016 | 6474 | 0.110 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 426 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2017 | 10175 | 0.110 |
Why?
|
| Muscle Contraction | 2 | 1995 | 1200 | 0.110 |
Why?
|
| Microcirculation | 1 | 2018 | 1272 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1074 | 0.110 |
Why?
|
| Young Adult | 10 | 2020 | 59179 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 3410 | 0.110 |
Why?
|
| Adolescent | 14 | 2020 | 88234 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2018 | 530 | 0.110 |
Why?
|
| Esophageal Motility Disorders | 1 | 1993 | 49 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2191 | 0.110 |
Why?
|
| Treatment Outcome | 17 | 2018 | 64568 | 0.110 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2016 | 1118 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 987 | 0.110 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2012 | 15 | 0.100 |
Why?
|
| Electrophysiology | 2 | 2011 | 1262 | 0.100 |
Why?
|
| Aging | 1 | 2011 | 8699 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2007 | 5912 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 1467 | 0.100 |
Why?
|
| Angioplasty | 1 | 2015 | 355 | 0.100 |
Why?
|
| Acid-Base Equilibrium | 1 | 2013 | 181 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2024 | 2789 | 0.100 |
Why?
|
| Thermogenesis | 1 | 2016 | 474 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 1250 | 0.100 |
Why?
|
| Lung | 7 | 2020 | 9998 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2021 | 1297 | 0.100 |
Why?
|
| Magnetics | 1 | 1995 | 597 | 0.100 |
Why?
|
| Jejunum | 1 | 1994 | 472 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2012 | 63 | 0.100 |
Why?
|
| Predictive Value of Tests | 11 | 2024 | 15251 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 2872 | 0.100 |
Why?
|
| Anastomosis, Roux-en-Y | 2 | 2007 | 86 | 0.100 |
Why?
|
| Mutation | 9 | 2020 | 30016 | 0.100 |
Why?
|
| Asbestos | 1 | 2013 | 251 | 0.100 |
Why?
|
| Pericardium | 3 | 2008 | 664 | 0.100 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 474 | 0.100 |
Why?
|
| Cell Survival | 3 | 2016 | 5780 | 0.100 |
Why?
|
| Neuromuscular Agents | 2 | 2005 | 148 | 0.100 |
Why?
|
| Creatinine | 1 | 2017 | 1896 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2015 | 584 | 0.100 |
Why?
|
| Diethylamines | 1 | 2011 | 3 | 0.100 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 1924 | 0.100 |
Why?
|
| Thoracoscopy | 3 | 2005 | 180 | 0.090 |
Why?
|
| Vinblastine | 2 | 2010 | 488 | 0.090 |
Why?
|
| Carcinogens | 1 | 2013 | 452 | 0.090 |
Why?
|
| Peptide Mapping | 1 | 2011 | 262 | 0.090 |
Why?
|
| Pancreatic Fistula | 1 | 2012 | 148 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 2100 | 0.090 |
Why?
|
| Antibodies, Blocking | 1 | 2011 | 243 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2018 | 4570 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 382 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 724 | 0.090 |
Why?
|
| Glycoproteins | 2 | 2016 | 2200 | 0.090 |
Why?
|
| Nephrotic Syndrome | 1 | 2014 | 390 | 0.090 |
Why?
|
| Luciferases | 1 | 2012 | 712 | 0.090 |
Why?
|
| Esophageal Neoplasms | 4 | 2005 | 1653 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2019 | 1596 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2014 | 3777 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 1394 | 0.090 |
Why?
|
| Stomach Diseases | 1 | 2011 | 134 | 0.090 |
Why?
|
| Pancreatectomy | 2 | 2012 | 811 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2017 | 5672 | 0.090 |
Why?
|
| Risk Assessment | 6 | 2019 | 23972 | 0.090 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 9529 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2012 | 1525 | 0.090 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 1896 | 0.090 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1848 | 0.090 |
Why?
|
| RNA, Neoplasm | 4 | 2010 | 749 | 0.080 |
Why?
|
| Calcitonin | 1 | 2011 | 329 | 0.080 |
Why?
|
| Autonomic Nervous System | 1 | 1995 | 704 | 0.080 |
Why?
|
| Monocytes | 1 | 2019 | 2565 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1779 | 0.080 |
Why?
|
| Aniline Compounds | 2 | 2014 | 1068 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2009 | 120 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 1995 | 2135 | 0.080 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2009 | 87 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2017 | 5863 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3792 | 0.080 |
Why?
|
| Epitopes | 2 | 2018 | 2501 | 0.080 |
Why?
|
| Amifostine | 1 | 2009 | 40 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 455 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 693 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 7 | 2017 | 6126 | 0.080 |
Why?
|
| Pyrophosphatases | 1 | 2009 | 142 | 0.080 |
Why?
|
| Intestine, Small | 1 | 1995 | 1207 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2006 | 1670 | 0.080 |
Why?
|
| Genetic Markers | 2 | 2012 | 2601 | 0.080 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 88 | 0.080 |
Why?
|
| Survival Analysis | 14 | 2012 | 10073 | 0.080 |
Why?
|
| Fracture Healing | 1 | 2011 | 445 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2009 | 201 | 0.080 |
Why?
|
| Leptin | 3 | 2005 | 1595 | 0.080 |
Why?
|
| Risk Factors | 9 | 2021 | 74115 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2009 | 200 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 2477 | 0.080 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1988 | 49 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2020 | 3045 | 0.080 |
Why?
|
| Neoplasms | 5 | 2023 | 22131 | 0.070 |
Why?
|
| Gastric Acidity Determination | 2 | 2006 | 56 | 0.070 |
Why?
|
| Pericardiectomy | 1 | 2008 | 46 | 0.070 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 519 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 717 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2019 | 2722 | 0.070 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 39063 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2014 | 2570 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7389 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 4 | 2020 | 5367 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2014 | 3461 | 0.070 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 1141 | 0.070 |
Why?
|
| In Situ Hybridization | 3 | 2007 | 1900 | 0.070 |
Why?
|
| Abdomen, Acute | 1 | 1988 | 122 | 0.070 |
Why?
|
| Biopsy | 1 | 2019 | 6762 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 3868 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 3 | 2005 | 420 | 0.070 |
Why?
|
| Maximum Tolerated Dose | 2 | 2009 | 883 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2016 | 2299 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 898 | 0.070 |
Why?
|
| Prospective Studies | 12 | 2024 | 54360 | 0.070 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 20074 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 12142 | 0.070 |
Why?
|
| Weight Loss | 2 | 2010 | 2682 | 0.070 |
Why?
|
| Calpain | 2 | 2010 | 146 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 3527 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 22115 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5463 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 2006 | 1085 | 0.070 |
Why?
|
| Macrophages | 2 | 2019 | 5758 | 0.070 |
Why?
|
| Peristalsis | 3 | 1995 | 60 | 0.070 |
Why?
|
| Ischemia | 1 | 1995 | 1884 | 0.070 |
Why?
|
| Tibia | 1 | 2012 | 1069 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 6520 | 0.070 |
Why?
|
| Chemistry | 1 | 2006 | 346 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2020 | 18937 | 0.070 |
Why?
|
| Neutrophils | 1 | 2019 | 3763 | 0.070 |
Why?
|
| Registries | 3 | 2018 | 8207 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2013 | 1372 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1963 | 0.070 |
Why?
|
| Carrier Proteins | 4 | 2012 | 4935 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 13441 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1335 | 0.070 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2005 | 12 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 4764 | 0.060 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2006 | 118 | 0.060 |
Why?
|
| Hodgkin Disease | 1 | 2013 | 1378 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 247 | 0.060 |
Why?
|
| Phosphoproteins | 4 | 2016 | 2446 | 0.060 |
Why?
|
| Mice, Knockout | 7 | 2021 | 14389 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2011 | 4117 | 0.060 |
Why?
|
| Joint Diseases | 1 | 2009 | 459 | 0.060 |
Why?
|
| Liver | 2 | 2021 | 7512 | 0.060 |
Why?
|
| European Union | 1 | 2006 | 157 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 11874 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2015 | 2635 | 0.060 |
Why?
|
| Antigens | 1 | 2011 | 1441 | 0.060 |
Why?
|
| Femur | 1 | 2011 | 1307 | 0.060 |
Why?
|
| Sex Factors | 4 | 2015 | 10548 | 0.060 |
Why?
|
| Sensitivity and Specificity | 6 | 2024 | 14648 | 0.060 |
Why?
|
| England | 1 | 2006 | 526 | 0.060 |
Why?
|
| Bariatrics | 1 | 2005 | 36 | 0.060 |
Why?
|
| Pleurodesis | 1 | 2005 | 46 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1521 | 0.060 |
Why?
|
| Talc | 1 | 2005 | 48 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 2915 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10432 | 0.060 |
Why?
|
| Time Factors | 9 | 2015 | 39913 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2019 | 3269 | 0.060 |
Why?
|
| Analysis of Variance | 5 | 2013 | 6224 | 0.060 |
Why?
|
| Aorta | 1 | 2012 | 2041 | 0.060 |
Why?
|
| Esophagectomy | 2 | 2006 | 467 | 0.060 |
Why?
|
| Smallpox | 1 | 2004 | 43 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 17629 | 0.060 |
Why?
|
| Pathology, Molecular | 1 | 2007 | 329 | 0.060 |
Why?
|
| Intestinal Obstruction | 1 | 1988 | 432 | 0.060 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2004 | 106 | 0.060 |
Why?
|
| Immunologic Memory | 1 | 2011 | 1355 | 0.060 |
Why?
|
| Noonan Syndrome | 1 | 2004 | 120 | 0.060 |
Why?
|
| Anthrax | 1 | 2004 | 83 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2016 | 2044 | 0.060 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2005 | 106 | 0.060 |
Why?
|
| Conditioning, Operant | 1 | 2005 | 309 | 0.060 |
Why?
|
| Pyridones | 1 | 2009 | 808 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3794 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 2178 | 0.060 |
Why?
|
| Proportional Hazards Models | 7 | 2016 | 12447 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2014 | 7583 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7995 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6188 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 5304 | 0.050 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 197 | 0.050 |
Why?
|
| Neurons | 2 | 2010 | 9438 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1088 | 0.050 |
Why?
|
| Arginine | 2 | 2018 | 933 | 0.050 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 189 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2010 | 1768 | 0.050 |
Why?
|
| Eating | 3 | 2005 | 1535 | 0.050 |
Why?
|
| Lymphatic Metastasis | 8 | 2014 | 2913 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2010 | 1144 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2009 | 1565 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2024 | 469 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 5780 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2018 | 4269 | 0.050 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 100 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2002 | 205 | 0.050 |
Why?
|
| Pressure | 2 | 2002 | 1150 | 0.050 |
Why?
|
| Colonic Polyps | 1 | 1987 | 553 | 0.050 |
Why?
|
| Propylamines | 2 | 2014 | 161 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2011 | 1874 | 0.050 |
Why?
|
| Barium Sulfate | 1 | 2002 | 180 | 0.050 |
Why?
|
| Patient Selection | 2 | 2011 | 4237 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2012 | 4160 | 0.050 |
Why?
|
| Epitope Mapping | 1 | 2002 | 297 | 0.050 |
Why?
|
| Cytokines | 4 | 2017 | 7373 | 0.050 |
Why?
|
| Probability | 1 | 2007 | 2475 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2849 | 0.050 |
Why?
|
| Protein Binding | 3 | 2018 | 9345 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2002 | 257 | 0.050 |
Why?
|
| Neoplasm Proteins | 3 | 2009 | 3607 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2005 | 665 | 0.050 |
Why?
|
| Lipids | 2 | 2010 | 3332 | 0.050 |
Why?
|
| Myocardium | 2 | 2012 | 4724 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1160 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2005 | 571 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 2014 | 9172 | 0.050 |
Why?
|
| Calcinosis | 1 | 2009 | 1469 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2009 | 2764 | 0.040 |
Why?
|
| Dilatation | 1 | 2002 | 306 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 352 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2003 | 662 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 2024 | 12966 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 11736 | 0.040 |
Why?
|
| Tennessee | 1 | 2000 | 119 | 0.040 |
Why?
|
| Laryngeal Diseases | 1 | 2003 | 243 | 0.040 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18221 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 1 | 2003 | 355 | 0.040 |
Why?
|
| Radiography | 2 | 2002 | 6961 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6925 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2178 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2005 | 768 | 0.040 |
Why?
|
| Drug Industry | 1 | 2006 | 788 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 4341 | 0.040 |
Why?
|
| Genome, Human | 2 | 2010 | 4421 | 0.040 |
Why?
|
| Oncogenes | 1 | 2005 | 1221 | 0.040 |
Why?
|
| DNA, Neoplasm | 4 | 2010 | 1743 | 0.040 |
Why?
|
| Esophageal Diseases | 1 | 2000 | 167 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2003 | 741 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2020 | 286 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2004 | 571 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4739 | 0.040 |
Why?
|
| Colonoscopy | 1 | 1987 | 1396 | 0.040 |
Why?
|
| Cyclization | 1 | 2018 | 59 | 0.040 |
Why?
|
| Body Composition | 2 | 2005 | 2426 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2005 | 626 | 0.040 |
Why?
|
| Polyribosomes | 1 | 2018 | 108 | 0.040 |
Why?
|
| Body Patterning | 1 | 2003 | 632 | 0.040 |
Why?
|
| Rabbits | 2 | 1995 | 4770 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2005 | 2661 | 0.040 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2002 | 238 | 0.040 |
Why?
|
| Blood Glucose | 3 | 2010 | 6390 | 0.040 |
Why?
|
| Length of Stay | 3 | 2020 | 6418 | 0.040 |
Why?
|
| Calreticulin | 1 | 2019 | 114 | 0.040 |
Why?
|
| Reoperation | 5 | 2013 | 4300 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2019 | 296 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2014 | 485 | 0.040 |
Why?
|
| Obesity | 4 | 2016 | 12933 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2020 | 22148 | 0.040 |
Why?
|
| Binding Sites, Antibody | 1 | 2018 | 337 | 0.040 |
Why?
|
| Cell Differentiation | 5 | 2020 | 11514 | 0.040 |
Why?
|
| Proteins | 2 | 2003 | 6030 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3705 | 0.040 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 12043 | 0.040 |
Why?
|
| Smoking | 3 | 2003 | 9050 | 0.040 |
Why?
|
| Genes, ras | 3 | 2008 | 654 | 0.040 |
Why?
|
| Cause of Death | 1 | 2008 | 3683 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 4236 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2713 | 0.040 |
Why?
|
| Single-Chain Antibodies | 1 | 2018 | 111 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2016 | 17 | 0.040 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 28 | 0.040 |
Why?
|
| Esophageal pH Monitoring | 1 | 2018 | 203 | 0.030 |
Why?
|
| Feasibility Studies | 3 | 2016 | 5239 | 0.030 |
Why?
|
| Linear Models | 1 | 2007 | 5866 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2013 | 610 | 0.030 |
Why?
|
| Ergocalciferols | 1 | 2017 | 110 | 0.030 |
Why?
|
| Abdomen | 1 | 1983 | 1128 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 1177 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
| Indoles | 1 | 2005 | 1830 | 0.030 |
Why?
|
| Vault Ribonucleoprotein Particles | 1 | 2016 | 11 | 0.030 |
Why?
|
| Annexin A4 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2016 | 20 | 0.030 |
Why?
|
| Adenoma | 1 | 1987 | 2159 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 20556 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 18381 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 91 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2002 | 1235 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1999 | 1122 | 0.030 |
Why?
|
| Skull | 2 | 2014 | 818 | 0.030 |
Why?
|
| TRPP Cation Channels | 1 | 2016 | 177 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2002 | 1469 | 0.030 |
Why?
|
| Nitroarginine | 1 | 1995 | 66 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3419 | 0.030 |
Why?
|
| Base Sequence | 3 | 2019 | 12421 | 0.030 |
Why?
|
| Quality of Life | 5 | 2023 | 13347 | 0.030 |
Why?
|
| Opossums | 1 | 1995 | 104 | 0.030 |
Why?
|
| Motor Activity | 1 | 2005 | 2714 | 0.030 |
Why?
|
| Quantum Theory | 1 | 1995 | 69 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2012 | 4391 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 272 | 0.030 |
Why?
|
| Dogs | 2 | 1995 | 3838 | 0.030 |
Why?
|
| Tubulin | 1 | 2019 | 692 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2005 | 1977 | 0.030 |
Why?
|
| Atropine | 1 | 1995 | 244 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 1692 | 0.030 |
Why?
|
| Cholinergic Agonists | 1 | 1995 | 75 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 149 | 0.030 |
Why?
|
| Genomics | 2 | 2014 | 5822 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 901 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3608 | 0.030 |
Why?
|
| Postgastrectomy Syndromes | 1 | 1994 | 3 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 1999 | 492 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1995 | 125 | 0.030 |
Why?
|
| Genes, erbB-2 | 1 | 1995 | 162 | 0.030 |
Why?
|
| Homeostasis | 2 | 2016 | 3321 | 0.030 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 1994 | 13 | 0.030 |
Why?
|
| COS Cells | 2 | 2010 | 1130 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 550 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2020 | 1526 | 0.030 |
Why?
|
| Radiotherapy Dosage | 2 | 2015 | 2897 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2012 | 1217 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1995 | 179 | 0.030 |
Why?
|
| Mercaptoethanol | 1 | 1994 | 62 | 0.030 |
Why?
|
| Parasympathetic Nervous System | 1 | 1995 | 143 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3451 | 0.030 |
Why?
|
| Piperazines | 1 | 2005 | 2521 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2014 | 67 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2878 | 0.030 |
Why?
|
| Haplorhini | 1 | 1995 | 525 | 0.030 |
Why?
|
| S-Nitrosothiols | 1 | 1994 | 35 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 3688 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2016 | 901 | 0.030 |
Why?
|
| Nitroso Compounds | 1 | 1994 | 71 | 0.030 |
Why?
|
| Fatty Liver | 2 | 2015 | 787 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 973 | 0.030 |
Why?
|
| Catecholamines | 1 | 1995 | 387 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 138 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1231 | 0.030 |
Why?
|
| Point Mutation | 2 | 2010 | 1595 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2005 | 5110 | 0.030 |
Why?
|
| Dietary Fats | 2 | 2016 | 1995 | 0.030 |
Why?
|
| Receptors, Leptin | 2 | 2005 | 350 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2014 | 166 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1995 | 393 | 0.030 |
Why?
|
| Models, Biological | 1 | 2010 | 9461 | 0.030 |
Why?
|
| Cats | 1 | 1995 | 975 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2005 | 3309 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2020 | 9643 | 0.030 |
Why?
|
| Equipment Design | 2 | 2006 | 3501 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2011 | 8311 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1550 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 1089 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 1336 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 1988 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1995 | 712 | 0.030 |
Why?
|
| Electrodes | 1 | 1995 | 610 | 0.030 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2012 | 22 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1602 | 0.030 |
Why?
|
| Tretinoin | 1 | 1995 | 519 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2016 | 639 | 0.030 |
Why?
|
| Alabama | 1 | 2012 | 108 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 908 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 1759 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3567 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2018 | 1569 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2014 | 568 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 789 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 1995 | 458 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 2079 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 343 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3605 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2007 | 12943 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2015 | 552 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2017 | 951 | 0.020 |
Why?
|
| Enteric Nervous System | 1 | 1995 | 213 | 0.020 |
Why?
|
| Punctures | 1 | 2013 | 364 | 0.020 |
Why?
|
| Proteinuria | 1 | 2014 | 606 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 2011 | 206 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2015 | 635 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 826 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12334 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 2639 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 2896 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 4611 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2007 | 3752 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 2015 | 534 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 529 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2011 | 411 | 0.020 |
Why?
|
| Dumping Syndrome | 1 | 1990 | 18 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 799 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1697 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3800 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2189 | 0.020 |
Why?
|
| Iohexol | 1 | 2012 | 204 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2014 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 2011 | 176 | 0.020 |
Why?
|
| Ligands | 1 | 2018 | 3268 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1894 | 0.020 |
Why?
|
| Body Weight | 2 | 2016 | 4614 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2016 | 1088 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 2011 | 118 | 0.020 |
Why?
|
| RNA Interference | 1 | 2019 | 2830 | 0.020 |
Why?
|
| DNA Primers | 2 | 2009 | 2817 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1999 | 2008 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2011 | 261 | 0.020 |
Why?
|
| Models, Animal | 1 | 2016 | 2109 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1995 | 1734 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 2821 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 2010 | 79 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2018 | 3145 | 0.020 |
Why?
|
| Gene Silencing | 2 | 2008 | 1503 | 0.020 |
Why?
|
| Cohort Studies | 5 | 2016 | 41457 | 0.020 |
Why?
|
| Octreotide | 1 | 1990 | 154 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2009 | 51 | 0.020 |
Why?
|
| Bronchi | 1 | 1994 | 846 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2010 | 228 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 506 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3117 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 699 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 2011 | 200 | 0.020 |
Why?
|
| Heart | 1 | 2002 | 4403 | 0.020 |
Why?
|
| Disulfides | 1 | 2011 | 464 | 0.020 |
Why?
|
| United States | 4 | 2019 | 72272 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 2650 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3599 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 814 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2010 | 265 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1738 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15828 | 0.020 |
Why?
|
| Osteocytes | 1 | 2010 | 192 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2004 | 3612 | 0.020 |
Why?
|
| Immunoblotting | 2 | 2007 | 1646 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 1392 | 0.020 |
Why?
|
| Mutagens | 1 | 2009 | 179 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2011 | 778 | 0.020 |
Why?
|
| Suction | 1 | 2010 | 266 | 0.020 |
Why?
|
| Pancreas | 2 | 2004 | 1690 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1098 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 1229 | 0.020 |
Why?
|
| Blotting, Southern | 2 | 2002 | 777 | 0.020 |
Why?
|
| Perfusion | 1 | 2013 | 1373 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 370 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2016 | 12116 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 913 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 1171 | 0.020 |
Why?
|
| Postoperative Care | 2 | 2010 | 1467 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 289 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 1966 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 1810 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 4845 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 901 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 510 | 0.020 |
Why?
|
| Intubation | 1 | 1988 | 139 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9313 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1492 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 1986 | 1116 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3601 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2008 | 134 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2008 | 184 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 15908 | 0.020 |
Why?
|
| Pyruvate Kinase | 1 | 2009 | 189 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1997 | 1909 | 0.020 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 1986 | 15 | 0.020 |
Why?
|
| Propensity Score | 1 | 2014 | 1911 | 0.020 |
Why?
|
| Splenic Vein | 1 | 1986 | 30 | 0.020 |
Why?
|
| Disease-Free Survival | 3 | 2006 | 6807 | 0.020 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1986 | 39 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2018 | 3095 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2013 | 1497 | 0.020 |
Why?
|
| Cysteine | 1 | 2011 | 891 | 0.020 |
Why?
|
| Cell Movement | 1 | 1999 | 5200 | 0.020 |
Why?
|
| RNA Editing | 1 | 2008 | 151 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 1002 | 0.020 |
Why?
|
| Gene Amplification | 2 | 2005 | 1087 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 1156 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2008 | 366 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2012 | 4137 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2700 | 0.020 |
Why?
|
| Duodenum | 1 | 1989 | 491 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2008 | 2057 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1996 | 2644 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3548 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 5835 | 0.020 |
Why?
|
| Mediastinum | 1 | 2006 | 266 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2009 | 1230 | 0.020 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2004 | 43 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 1503 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 2050 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2734 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 77 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 1125 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 412 | 0.020 |
Why?
|
| Wound Healing | 1 | 2016 | 2802 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2011 | 1013 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2009 | 1605 | 0.010 |
Why?
|
| Thoracostomy | 1 | 2005 | 74 | 0.010 |
Why?
|
| Insufflation | 1 | 2005 | 63 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 2007 | 393 | 0.010 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2005 | 84 | 0.010 |
Why?
|
| Carboxypeptidase H | 1 | 2004 | 9 | 0.010 |
Why?
|
| Antibodies | 1 | 2012 | 2414 | 0.010 |
Why?
|
| Proprotein Convertase 1 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1986 | 207 | 0.010 |
Why?
|
| Amphetamine | 1 | 2005 | 224 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 29868 | 0.010 |
Why?
|
| Growth Plate | 1 | 2006 | 272 | 0.010 |
Why?
|
| Exons | 1 | 2010 | 2381 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 361 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2004 | 223 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 217 | 0.010 |
Why?
|
| Small Molecule Libraries | 1 | 2009 | 733 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3074 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1490 | 0.010 |
Why?
|
| Response Elements | 1 | 2005 | 309 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2006 | 613 | 0.010 |
Why?
|
| Kyphosis | 1 | 2006 | 237 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1738 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 1642 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2005 | 318 | 0.010 |
Why?
|
| Immunoassay | 1 | 2007 | 744 | 0.010 |
Why?
|
| Pituitary Hormones | 1 | 2004 | 182 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1624 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2009 | 1437 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4571 | 0.010 |
Why?
|
| Body Fluids | 1 | 2004 | 320 | 0.010 |
Why?
|
| Disease Progression | 2 | 2015 | 13495 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4533 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2006 | 1575 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1134 | 0.010 |
Why?
|
| Receptor, erbB-2 | 2 | 2008 | 2553 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2002 | 57 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2002 | 223 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2014 | 3027 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6338 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1779 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2006 | 711 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2005 | 655 | 0.010 |
Why?
|
| Incidence | 1 | 2000 | 21337 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 2546 | 0.010 |
Why?
|
| Recurrence | 2 | 2005 | 8426 | 0.010 |
Why?
|
| Tooth | 1 | 2003 | 210 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2005 | 42188 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2003 | 557 | 0.010 |
Why?
|
| Carcinoma in Situ | 1 | 1987 | 791 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2011 | 1799 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13245 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2006 | 1964 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1415 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 14018 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2014 | 3533 | 0.010 |
Why?
|
| Ion Channels | 1 | 2005 | 1039 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6051 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2003 | 400 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2005 | 1386 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5293 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 783 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2004 | 960 | 0.010 |
Why?
|
| Remission Induction | 1 | 2006 | 2391 | 0.010 |
Why?
|
| Cocaine | 1 | 2005 | 958 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6074 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 974 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2005 | 825 | 0.010 |
Why?
|
| Paxillin | 1 | 1999 | 86 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2002 | 1096 | 0.010 |
Why?
|
| Spine | 1 | 2006 | 1112 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5305 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6483 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 768 | 0.010 |
Why?
|
| Karnofsky Performance Status | 1 | 1998 | 166 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2004 | 944 | 0.010 |
Why?
|
| Video Recording | 1 | 2003 | 965 | 0.010 |
Why?
|
| Laryngoscopy | 1 | 2003 | 707 | 0.010 |
Why?
|
| Surgical Staplers | 1 | 1997 | 34 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5034 | 0.010 |
Why?
|
| Extremities | 1 | 2003 | 867 | 0.010 |
Why?
|
| Keratins | 1 | 1999 | 498 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 2231 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2006 | 2241 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1315 | 0.010 |
Why?
|
| Insulin | 3 | 2003 | 6593 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2005 | 1768 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1997 | 375 | 0.010 |
Why?
|
| Child | 2 | 2005 | 80079 | 0.010 |
Why?
|
| Prostate | 1 | 2004 | 1773 | 0.010 |
Why?
|
| Matrix Metalloproteinase 11 | 1 | 1995 | 15 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 2425 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2001 | 491 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 6233 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 2459 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 1808 | 0.010 |
Why?
|
| Motivation | 1 | 2005 | 2003 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 2806 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 12978 | 0.010 |
Why?
|
| Dissection | 1 | 1997 | 297 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4919 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 167 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2005 | 2595 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1996 | 278 | 0.010 |
Why?
|
| Disease Management | 1 | 2004 | 2506 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 2852 | 0.010 |
Why?
|
| Deglutition | 1 | 1994 | 208 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 2185 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1994 | 205 | 0.010 |
Why?
|
| Palliative Care | 1 | 2008 | 3592 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4512 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1994 | 395 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9476 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1995 | 697 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 9604 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 671 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4910 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1999 | 3593 | 0.010 |
Why?
|
| Pulse | 1 | 1990 | 217 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9586 | 0.010 |
Why?
|
| Health Status | 1 | 2003 | 4075 | 0.010 |
Why?
|
| Gastrointestinal Hormones | 1 | 1990 | 101 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3730 | 0.010 |
Why?
|
| Stromal Cells | 1 | 1995 | 1329 | 0.010 |
Why?
|
| Sarcoma | 1 | 2001 | 1800 | 0.010 |
Why?
|
| Carcinoma | 1 | 2001 | 2327 | 0.010 |
Why?
|
| Pylorus | 1 | 1989 | 86 | 0.000 |
Why?
|
| Duodenal Neoplasms | 1 | 1989 | 114 | 0.000 |
Why?
|
| Glucagon | 1 | 1990 | 531 | 0.000 |
Why?
|
| Prevalence | 1 | 2005 | 15689 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1994 | 3591 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1983 | 8472 | 0.000 |
Why?
|
| Portal System | 1 | 1986 | 49 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 1623 | 0.000 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1986 | 64 | 0.000 |
Why?
|
| Liver Circulation | 1 | 1986 | 159 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17878 | 0.000 |
Why?
|
| Placebos | 1 | 1990 | 1667 | 0.000 |
Why?
|
| Collateral Circulation | 1 | 1986 | 293 | 0.000 |
Why?
|
| Phenotype | 1 | 2003 | 16571 | 0.000 |
Why?
|
| Liver Function Tests | 1 | 1986 | 524 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1995 | 2917 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1986 | 831 | 0.000 |
Why?
|
| Diarrhea | 1 | 1990 | 1317 | 0.000 |
Why?
|
| Melanoma | 1 | 2001 | 5697 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 11106 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 10754 | 0.000 |
Why?
|
| Brain | 1 | 2006 | 27101 | 0.000 |
Why?
|
| Stomach Neoplasms | 1 | 1989 | 1453 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 20988 | 0.000 |
Why?
|